BioXcel Therapeutics将于2025年8月27日公布Serenity at-Home关键性3期安全试验的顶线结果,该试验用于急性治疗与双相情感障碍或精神分裂症相关的躁动
BioXcel Therapeutics将于2025年8月27日公布Serenity at-Home关键性3期安全试验的顶线结果,该试验用于急性治疗与双相情感障碍或精神分裂症相关的躁动
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.